Figure S2.
Analysis of protein expression in siRNA-treated cells.
(A–G) MDA-MB-231 or Hs578T human breast cancer cells were treated with the indicated siRNAs for 72 h and analyzed by immunoblotting analysis with the indicated antibodies. Equal loading was controlled using GAPDH antibody. Molecular weights are in kD.